journal article·2004-10Open access

Development and characterization of a canine oral mucosa equivalent in a serum‐free environment

Junhui Song, Kenji Izumi, Thomas Lanigan, Stephen E. Feinberg

Abstract

Abstract The objectives of this study were to develop a serum‐free system for culturing canine oral keratinocytes, the construction and characterization of a canine ex vivo produced oral mucosa equivalent (EVPOME), and transduction green fluorescent protein (GFP) into keratinocytes as a post‐grafting tracking marker. Dissociated canine buccal mucosa keratinocytes were cultured in a chemically defined serum‐free medium, Epilife™. First‐passage keratinocytes were transfected with the GFP gene using a lentiviral vector, sorted by flow cytometer and seeded onto a dermal equivalent, AlloDerm® to form EVPOMEs. The EVPOME was characterized by histology and immunohistochemistry, for p63, Ki‐67, and involucrin. Laser confocal microscopy was used to locate GFP‐transfected keratinocytes within the EVPOME. Cultured canine oral keratinocytes grew rapidly over the first three passages and then the proliferative rate decreased. The canine EVPOME formed a well‐stratified epithelial layer. The majority of p63 and Ki‐67 immunopositive cells were located in the basal layer whereas cytoplasmic involucrin expression was seen in the suprabasal layers, similar to native canine buccal mucosa. Under laser confocal microscopy, significant green fluorescence was observed throughout the EVPOME. In conclusion, canine EVPOMEs were successfully fabricated in a defined serum‐free system with similar characteristics to native buccal mucosa. GFP‐transfected canine oral keratinocytes could be identified within the EVPOME. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res 71A: 143–153, 2004
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Corneal Surgery and Treatments · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. 10.1053/joms.2001.2049010.1053/joms.2001.20490 ↗
2. 10.1054/ijom.2002.036510.1054/ijom.2002.0365 ↗
3. 10.1177/0022034500079003030110.1177/00220345000790030301 ↗
4. 10.1089/10763270376268764510.1089/107632703762687645 ↗
5. 10.1159/00007503410.1159/000075034 ↗
6. 10.1016/S0738-081X(00)00196-610.1016/S0738-081X(00)00196-6 ↗
7. 10.1006/viro.2001.086810.1006/viro.2001.0868 ↗
8. 10.1177/03009858860230020510.1177/030098588602300205 ↗
9. 10.1111/j.1600-0625.1997.tb00162.x10.1111/j.1600-0625.1997.tb00162.x ↗
10. 10.1111/1523-1747.ep1252534210.1111/1523-1747.ep12525342 ↗
11. 10.1016/S0142-9612(02)00108-410.1016/S0142-9612(02)00108-4 ↗
12. 10.1177/03009858910280020510.1177/030098589102800205 ↗
13. 10.1016/S0278-2391(89)80011-410.1016/S0278-2391(89)80011-4 ↗
14. Ian Freshney R · 2000 · 321
15. 10.1016/S0278-2391(99)90077-010.1016/S0278-2391(99)90077-0 ↗
16. 10.1016/j.tiv.2003.08.00910.1016/j.tiv.2003.08.009 ↗
17. 10.1182/blood.V89.3.77610.1182/blood.V89.3.776 ↗
18. 10.1046/j.0022-202x.2001.01280.x10.1046/j.0022-202x.2001.01280.x ↗
19. 10.1016/S0303-7207(01)00452-X10.1016/S0303-7207(01)00452-X ↗
20. 10.1054/ijom.2002.033310.1054/ijom.2002.0333 ↗
21. 10.1038/sj.onc.120369510.1038/sj.onc.1203695 ↗
22. 10.1034/j.1600-0625.2001.010002080.x10.1034/j.1600-0625.2001.010002080.x ↗
23. 10.1007/BF0262365710.1007/BF02623657 ↗
24. 10.1111/1523-1747.ep1239686410.1111/1523-1747.ep12396864 ↗
25. Strachan DS · 1994 · 298
26. 10.1016/S1097-2765(00)80275-010.1016/S1097-2765(00)80275-0 ↗
27. 10.1073/pnas.06103209810.1073/pnas.061032098 ↗
28. 10.1096/fsb2fj000324com10.1096/fsb2fj000324com ↗
29. 10.1016/S0959-437X(00)00211-210.1016/S0959-437X(00)00211-2 ↗
30. 10.1002/path.115610.1002/path.1156 ↗
31. 10.1053/joms.2001.2048910.1053/joms.2001.20489 ↗
32. 10.1002/1521-2254(200009/10)2:5<308::AID-JGM131>3.0.CO;2-310.1002/1521-2254(200009/10)2:5<308::AID-JGM131>3.0.CO;2-3 ↗
33. 10.1089/1043034015248027610.1089/10430340152480276 ↗
34. 10.1128/JVI.76.3.1496-1504.200210.1128/JVI.76.3.1496-1504.2002 ↗
35. 10.1046/j.1365-2230.2003.01191.x10.1046/j.1365-2230.2003.01191.x ↗
36. Epidermal stem cells: characteristics and use in tissue engineering and gene therapy